Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding

Podcast: Business Of Biotech · Ben Comer

Opublikowano: 2026-10-05

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI" company using synthetic DNA switches and cancer-binding lipid nanoparticles to transform cancer cells into immune therapy-producing factories in vivo. Cyriac also discusses China’s newest five-year plan for biotech (2026 to 2030), why U.S. funding cycles are pushing innovation offshore, and how a U.S. sovereign wealth fund could support preclinical and early-stage drug development leadership at home. Access this and hundreds of episodes of the Bu...